FindTrial
Sign In

Comparison of two different techniques of Fascia Iliaca block in total hip arthroplasty.

Comparison of postoperative analgesic efficacy of two different techniques of Fascia Iliaca block in patients undergoing total hip replacement.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2014/02/004378
Enrollment
40
Registered
2014-02-04
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Post operative pain in patients undergoing total hip arthroplasty

Interventions

Intervention1: Modified suprainguinal fascia iliaca block: DOSE: 40 ml of 0.2% bupivacaine FREQUENCY: single shot injection ROUTE OF ADMINISTRATION: injection in the deep fascial plane 1 cm above th

Sponsors

Department of Anaesthesiology AIIMS New Delhi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ASA I - II patients (20 patients for each group, aged 25-65 years; weight 50-80 kg) undergoing unilateral total hip arthroplasty.

Exclusion criteria

Exclusion criteria: 1. ASA III / IV 2. Bilateral / Revision THA 3. Morbid obesity (BMI >= 40) 4. History of focal neurological deficit 5. History of sensory or motor disorders of limb to be operated 6. Patients with contraindication to subarachnoid block 7. History of allergy to local anaesthetics, clonidine 8. History of regular opioid use 9. Infection at puncture site for both approaches to fascia iliaca block 10. Patient refusal to take part in the study. 11. Inability to comprehend VAS pain assessment scale 12. Inability to understand the use of PCA device

Design outcomes

Primary

MeasureTime frame
postoperative morphine consumption in first 24 hours in patients undergoing total hip arthroplasty and to compare the morphine sparing effect of two techniques of fascia iliaca block in first 24 hours.Timepoint: comparison of morphine consumption between the comparator and interventional group at 6, 12 and 24 hours post total hip arthroplasty.—

Secondary

MeasureTime frame
to assess the incidence of adverse effects in the intraoperative and postoperative period.Timepoint: to assess the side effects at 6, 12 and 24 hours in intraoperative and postoperative period—

Countries

India

Contacts

Public ContactRAVINDER KUMAR PANDEY

AIIMS

ravindrapandey1972@gmail.com9868397817

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026